ABSTRACT

Acute generalized exanthematous pustulosis (AGEP) is a disease characterized by acute non-follicular sterile pustules on erythematous ground, which is usually triggered by drug use. In general, related to drugs such as beta-lactams, macrolides and calcium channel blockers. Most patients show spontaneous remission. Hydroxychloroquine is a very rare drug that causes AGEP and it is used in some dermatological and rheumatic diseases due to its anti-inflammatory and immunosuppressive effects. Our 53-year-old female patient developed AGEP after hydroxychloroquine used for the treatment of rheumatoidarthritis. The patient had resistance to steroid treatment and her complaints have been increased. The patient was treated with cyclosporine and his complaints were completely relieved.

References

1Fernando SL. Acute generalised exanthematous pustulosis. Australas J Dermatol 2011; 53: 87-92.

2Yalçın B, Çakmak S, Yıldırım B. Successful treatment of hydroxychloroquine1-ınduced recalcitrant acute generalized exanthematous pustulosiswith cyclosporine: case report and literature review. Ann Dermatol 2015; 27: 431-434.

3Tamir E, Wohl Y, Mashiah J, et al. Acute generalized exanthematous pustulosis: a retrospectiveanalysisshowing a clear predilection for women. Skinmed 2006; 5: 186-188.

4Davidovici B, Dodiuk-Gad R, Rozenman D, et al. Profile of acute generalized exanthematous pustulos is in Israelduring 2002-2005: results of the RegiSCAR Study. Isr Med Assoc J 2008; 10: 410-412.

5Di Lernia V, Grenzi L, Guareschi E, et al. Rapidclearing of acute generalized exanthematous pustulos is after administration of ciclosporin. Clinical and Experimental Dermatology 2009; 34: e757-e759. doi: 10.1111/j.1365-2230.2009.03480.x

6Baker H, Ryan TJ. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771-793.

7Beylot C, Bioulac P, Doutre MS. Acute generalized exanthematic pustuloses (fourcases) Ann Dermatol Venereol 1980; 107: 37-48.

8Sidoroff A, Halevy S, Bavinck JNB, et al. Acute generalized exanthematous pustolosis: a clinical reaction pattern. J Cutan Pathol 2001; 28: 113-119.

9Bailey K, Mckee D, Wisme J, et al. Acute generalized exanthematous pustulosis ınducedby hydroxychloroquine: first case report in canada and review of the literature. Journal of Cutaneous Medicine and Surgery 2013; 17: 414-418.

10Gebhardt M, Lustig A, Bocker T, et al. Acute generalized exanthematous pustulosis (AGEP): manifestation of drugallergytopropicillin. Contact Dermatitis 1995; 33: 204-205.

11Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinationalcase-controlstudy (EuroSCAR) Br J Dermatol 2007; 157: 989-996.

12Burrows NP, Jones RR. Pustular drugeruptions: a histopathological spectrum. Histopathology. 1993; 22: 569-573.

13Paradisi A, Bugatti L, Sisto T, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature. ClinTher 2008; 30: 930-940.

14Auer-Grumbach P, Pfaffenthaler E, Soykr HP. Pustulosis acuta generalisata is a post-streptococcal disease and is distinct from acute generalized exanthematous pustulosis. Br J Dermatol 1995; 133: 135-139.

15Castner NB, Harris JC, Motaparthi K. Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine. Dermatol Ther 2018; 31: e12660. doi: 10.1111/dth.12660

Efficacy of Cyclosporine in Hydroxycholorokine Induced Steroid Resistant Acute Generalized Exanthematous Pustulosis

ABSTRACT

References